NANOG and cancer: The study was conducted to evaluate the immunohistochemical expression of cancer stem cell markers (CSM) OCT-4 and NANOG in OSMF (OSMF) patients, OSCC transformed from OSMF (OSCC+OSMF) patients, and OSCC not transformed from OSMF (OSCC-OSMF) patients.